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Abstract
Background: Humans are continuously exposed to particles in the gastrointestinal tract. Exposure may occur directly
through ingestion of particles via food or indirectly by removal of inhaled material from the airways by the mucociliary
clearance system. We examined the effects of food-grade particle exposure on vasomotor function and systemic
oxidative stress in an ex vivo study and intragastrically exposed rats.
Methods: In an ex vivo study, aorta rings from naïve Sprague-Dawley rats were exposed for 30 min to food-grade TiO2
(E171), benchmark TiO2 (Aeroxide P25), food-grade vegetable carbon (E153) or benchmark carbon black (Printex 90).
Subsequently, the vasomotor function was assessed in wire myographs. In an in vivo study, lean Zucker rats were
exposed intragastrically once a week for 10 weeks to vehicle, E171 or E153. Doses were comparable to human daily
intake. Vasomotor function in the coronary arteries and aorta was assessed using wire myographs. Tetrahydrobiopterin,
ascorbate, malondialdehyde and asymmetric dimethylarginine were measured in blood as markers of oxidative stress
and vascular function.
Results: Direct exposure of E171 to aorta rings ex vivo increased the acetylcholine-induced vasorelaxation and
5-hydroxytryptamine-induced vasocontraction. E153 only increased acetylcholine-induced vasorelaxation, and
Printex 90 increased the 5-hydroxytryptamine-induced vasocontraction, whereas Aeroxide P25 did not affect the
vasomotor function. In vivo exposure showed similar results as ex vivo exposure; increased acetylcholine-induced
vasorelaxation in coronary artery segments of E153 and E171 exposed rats, whereas E171 exposure altered 5-
hydroxytryptamine-induced vasocontraction in distal coronary artery segments. Plasma levels of markers of
oxidative stress and vascular function showed no differences between groups.
Conclusion: Gastrointestinal tract exposure to E171 and E153 was associated with modest albeit statistically significant
alterations in the vasocontraction and vasorelaxation responses. Direct particle exposure to aorta rings elicited a similar
type of response. The vasomotor responses were not related to biomarkers of systemic oxidative stress.
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Gastrointestinal exposure, Endothelial dysfunction
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Background
Humans are continuously exposed to particles through
the gastrointestinal (GI) tract. Particles are widely used in
food products and drugs as pigments or as additives.
Another important source of oral exposure is inhaled par-
ticles because particles in the upper respiratory tract are
removed by the mucociliary clearance system and subse-
quently swallowed [1]. It has been estimated that 60% of
the inhaled mass of particles is cleared to the stomach
after 200 h [2]. Thus, inhalation of pigments such as TiO2
inadvertently gives rise to GI exposure. Although there is
an increase in the use of engineered nanoparticles as food
additives, there is limited knowledge about the possible
detrimental effects of oral exposure.
There is a relatively large body of literature showing
that pulmonary exposure to particles is associated with
vasomotor dysfunction and progression of atheroscler-
osis [3, 4], which are important intermediate steps in the
development of cardiovascular disease. The underlying
pathophysiological mechanisms are complex and poorly
understood; however particle-generated oxidative stress
seems to be a key component [5]. We have previously
shown that oral exposure to nanosized carbon black in
the form of Printex 90 was associated with endothelial
dysfunction, which was observed as reduced acetylcho-
line (ACh)-induced vasorelaxation in the aorta, in both
lean and obese Zucker rats [6]. Endothelial dysfunction,
a hallmark in development of atherosclerosis, is charac-
terized by endothelial nitric oxide synthase (eNOS)
uncoupling and a concomitant shift from production of
nitric oxide (NO) to superoxide anion radicals and per-
oxynitrite. This event results in decreased NO bioavail-
ability, which is associated with vasomotor dysfunction.
The increased production of superoxide anion radicals
and peroxynitrite promotes a local milieu of oxidative
stress in the endothelial cells. Uncoupling of eNOS can
be caused by reduced bioavailability of tetrahydrobiop-
terin (BH4), which is a cofactor for eNOS [7]. BH4 reacts
readily with reactive oxygen species and is thus suscep-
tible to depletion during oxidative stress [7]. It has been
shown that ascorbic acid improves the NO-dependent
vasorelaxation in arteries via higher BH4 bioavailability
[8], further emphasizing the role of oxidative stress in-
volved in vasomotor dysfunction. Systemic oxidative
stress is also considered to be an important intermediate
step in the development of vasomotor dysfunction.
Decreased levels of antioxidants (e.g., ascorbic acid) or
increased levels of lipid oxidation products such as mal-
ondialdehyde (MDA) are typically used as indicators of
oxidative stress.
This study aimed to investigate the effect of repeated
intragastric administration of food-grade particles on
vasomotor function and systemic oxidative stress. Due
to the analogy between air pollution particles and
nanomaterials, we hypothesize that intragastric exposure
to particles could result in similar effects as inhalation
exposure. Carbon-based materials such as Printex 90
and other nanomaterials are not likely to be ingested on
a regular basis by consumers. However, the European
Food and Safety Authority (EFSA) has approved the use
of carbon-based material from vegetable origin (E153)
and TiO2 (E171) as food coloring substances [9, 10] and
there is no established upper threshold limit of intake.
E153 is used as a black colorant in candy and as a
pharmaceutical product for the treatment of acute poi-
soning and diarrhea. E171 is used as a white colorant in
e.g., candy and dressings. It should be emphasized that
these coloring agents are not nanomaterials per se, al-
though there is a fraction of particles in the nanosize
range in the samples. Nevertheless, they are highly rele-
vant materials in particle toxicology because humans are
exposed to these particles on a daily basis. First, we
compared the effect of E171 and E153 to benchmark
counterparts (Aeroxide P25 and Printex 90, respectively)
on vasomotor function ex vivo in isolated aorta seg-
ments from naïve rats. Aeroxide P25 and Printex 90
have been used extensively in nanotoxicology and inhal-
ation toxicology. We have used Aeroxide P25 and
Printex 90 as benchmark particles, but there is not suffi-
cient experimental evidence to regard them as positive
controls for cardiovascular disease endpoints. Subse-
quently, we investigated in vivo effects, i.e., vasomotor
function in the aorta and coronary arteries and systemic
oxidative stress in lean Zucker rats after repeated oral
administration of E171 and E153. The lean Zucker rat
was chosen as an animal model, because of previous
findings of endothelial dysfunction in the aorta in ani-
mals exposed to Printex 90 [6].
We have used one weekly exposure because repeated
oral gavages may cause adverse effects in the rats. In
addition, there is day-to-day variation in the exposure to
E153 and E171, related to the intake of food (i.e. high
exposure on certain days and little exposure on other
days of the week). According to EFSA, the average daily
intake of E171 is 1.8–10.4 mg/kg in children, whereas
the 95% percentile is 4.9–32.4 mg/kg per day [10]. This
corresponds to average weekly accumulated doses of 34
to 227 mg/kg for high-consumers. In comparison, the
intake of E171 is lower in the elderly (mean: 0.4–4.5 mg/
kg/day; 95% percentile: 1.2–10.7 mg/kg/day). The vege-
table carbon doses were selected from an earlier study
with Printex 90 [6]. It has been estimated that the mean
dietary exposure to vegetable carbon is 3.0–29.7 and
3.7 mg/kg bw per day in children and adults respectively
[9]. The high-level consumers have a daily intake of
15.3–79.1 and 28.1 mg/kg bw in children and adults, re-
spectively [9]. Thus, the doses of E153 (i.e., 0.64 and
6.4 mg/kg) corresponds to the average daily dose in
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humans. The purpose of the ex vivo study was to compare
the effect of the food-grade particles with their respective
pigment-grade particles. Thus, the concentrations are ra-
ther high as compared to realistic concentrations after
intake of E153 and E171. The concentrations of 10 and
100 μg/ml of E153 were identical to previous experiments
on Printex 90 in aorta rings from mice [11]. The concen-
trations of TiO2 in the ex vivo study was based on the
average daily intake in children (i.e. 10.4 mg/kg/day),
bodyweight (35 kg), blood volume (2500 ml) and either
complete or 10% uptake of particles.
Results
Particle characterization
The particle size was assessed in dry form by transmis-
sion electron microscopy (TEM) (Fig. 1 and Table 1).
Three size groups for E171 were observed from the
TEM images; 135 ± 46 nm, 305 ± 61, 900 ± 247 nm and
two size groups of E153; 50 ± 10 nm and 950 ± 200 nm.
The specific surface areas were 1935 and 7.9 m2/g for
E153 and E171, respectively (Table 1). Aeroxide P25
(identical to NM105 in the European Commission’s Joint
Research Centre) and Printex 90 have been thoroughly
characterized in previous investigations [12, 13]. The
specific surface areas are 295–338 and 46 m2/g for
Printex 90 and Aeroxide P25, respectively.
The zeta potentials of the E171 and E153 particles in
PBS were measured using PALS (phase analysis light
scattering) and M3-PALS. E171 had a zeta potential of
− 37.2 ± 2.0 mV and E153 of –24.7 ± 1.6 mV (Table 1).
The results from single PALS measurements gave un-
usually high fluctuations; thus the hydrodynamic particle
size was also measured with DLS on the same instrument.
The DLS analysis showed a presence of microparticles (i.e.
size of 6 μm and larger) and the suspension was not
stable. The fluctuations in the zeta potential measure-
ments might be caused by noise from aggregation of parti-
cles or sedimentation during the measurement.
The hydrodynamic particle size distribution was mea-
sured by the Nanoparticle Tracking Analysis (NTA)
a1 a2
b c
Fig. 1 TEM images of E153 and E171. Dry particle size and morphology of E153 and E171 was determined by TEM images. (a1) and (a2) are images of
E171, magnification 5800×. Three size groups of E171 particles were observed in the pictures. (b) and (c) are images of E153, magnification 5800× (b)
and 44,000× (c). Two size groups of particles were observed for E153. Scale bars are 500 nm
Table 1 Primary particle size, charge and specific surface area of
E171 and E153
DLS Mean (nm) Particle size
(TEM) Mean (nm)
Surface area
(BET) m2/g
Zeta
potential mV
E171 19 (1%) 135 ± 46 (27) 7.9 −37.2 ± 2.0
880 ± 390 (94%) 305 ± 61 (12)
3200 (5%) 900 ± 247 (5)
E153 283 ± 60 50 ± 10 (12) 1935 − 24.7 ± 1.6
950 ± 200 (20)
Dry particle size was measured by TEM analysis. Three size groups were observed
from E171 and two size groups from E153. Surface area was determined by BET
analysis. Zeta potential was determined by PALS. The data on TEM, surface area,
and zeta potential are expressed as the mean ± SD (number of particles is
indicated in the brackets). The hydrodynamic size distribution was also measured
by DLS. Three size distributions were observed for E171. Numbers in brackets
indicate the intensity distribution
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(Table 2). Particles were suspended in DMEM in the ex vivo
study and filtered water + 2% fetal bovine serum (FBS) in
the in vivo study. Graphs of the hydrodynamic particle size
distribution analysis are shown in Fig. 2. E171 and E153,
dispersed in DMEM or filtered water, had a similar hydro-
dynamic particle size (E171: 203 ± 75 nm in DMEM and
270 ± 25 nm in filtered water; E153, 204 ± 58 nm in
DMEM and 230 ± 24 nm in filtered water) (Table 2). Only
10% of the food-grade particles in DMEM suspensions
were below 100 nm, whereas 50% of the benchmark parti-
cles (Aeroxide P25 and Printex 90) were below 100 nm.
Ex vivo effect of food-grade and benchmark particles on
the vasomotor function
Aorta rings from naïve rats were incubated for 30 min
with E171 (14 μg/ml and 140 μg/ml), E153 (10 μg/ml
and 140 μg/ml), Aeroxide P25 (14 μg/ml and 140 μg/ml)
or Printex 90 (10 μg/ml and 100 μg/ml). We used a
30 min incubation period because it has been shown
that ex vivo exposure to Printex 90 decreased
ACh-induced vasorelaxation and increased the vasocon-
traction response to phenylephrine in aorta rings after
exposure to 100 μg/ml for 30 min [11].
The vessel rings were exposed to cumulative increasing
concentrations of vasoactive compounds to assess ACh-
induced endothelium-dependent vasorelaxation (Fig. 3),
nitroglycerine (NTG)-induced endothelium-independent
vasorelaxation (Fig. 4) or 5-hydroxytryptamine (5-HT)-in-
duced vasocontraction (Fig. 5). Log EC50 and Emax values
of the vasomotor responses are shown in Table 3. The
analysis demonstrated a slightly increased maximal effect
value (Emax) of the ACh-dependent vasorelaxation in E171
and E153 exposed aorta rings (56.3%, 95% CI: 52.5–61.3%)
and 57.5% (95% CI: 52.7–64.6%) respectively, compared to
control group of 42.9% (95% CI: 38.7–48.6%) (Fig. 3).
There were no differences in the NTG-mediated
endothelium-independent vasorelaxation response (Fig. 4).
As expected, co-incubation with NG-nitro-L-arginine me-
thyl ester (L-NAME), an inhibitor of NOS, in the organ
bath abolished the ACh-mediated vasorelaxation (Fig. 3).
Thus, the results indicate an altered endothelium-
dependent vasorelaxation response. The E171 and Printex
90 exposure also increased the Emax value of the 5-HT-
mediated vasocontraction (Fig. 5). There was no effect on
vasomotor when exposing rings with Aeroxide P25.
In vivo effect of food-grade particles on the vasomotor
function in rats after intragastric administration of E171
and E153
The vasomotor function in coronary arteries and aorta
were assessed in rats after intragastric administration of
E171, E153 or vehicle, once a week for 10 weeks. The
Log EC50 and Emax values are shown in Table 4. The
maximal ACh-mediated endothelium-dependent
vasorelaxation response was slightly increased in the
proximal left anterior descending (LAD) artery of the
low-dose E153 exposed rats (111.1%, 95% CI:
104.3–119.1%) compared to the control group of 98.2%
(95% CI: 94.5–102.0%) (Fig. 6). There was also increased
maximal ACh-mediated endothelium-dependent vasore-
laxation response in the distal LAD in the high-dose
E153 exposed rats (111.5%, 95% CI: 103.5–120.6%) com-
pared to the control group of 93.3% (95% CI:
87.1–100.4%), and in the high-dose E171 exposed rats
(112.0%, 95% CI: 101.9–124.7%), whereas there was no
difference in the aorta (Fig. 6). The Emax value of the
NTG-mediated endothelium-independent vasorelax-
ation response was unaffected (Fig. 7). The LogEC50 of
the E171 high-dose exposed rats was shifted to the left
(− 7.8, 95% CI: -8.0 to − 7.7) compared to the control
(− 7.5, 95% CI: -7.6 to − 7.4). This effect was not
observed in any of the other exposures and segments.
Overall, the findings on the NTG- and ACh- mediated
responses suggest that the altered ACh-mediated
vasorelaxation response is indeed an endothelium-
dependent effect on the vasomotor function. The
5-HT-mediated vasocontraction response was increased
in the distal (50 mg/kg) LAD (Fig. 8).
Biochemical parameters in plasma of rats after
intragastric administration of E171 and E153
Plasma levels of vitamin C (calculated as ascorbate +
dehydroascorbic acid (DHA; an oxidized form of ascor-
bate)), BH4 and the oxidized form dihydrobiopterin
(BH2), asymmetric dimethylarginine (ADMA) and L-
arginine (L-Arg) were measured to assess systemic oxi-
dative stress and imbalances in the NO bioavailability.
ADMA competes with arginine as a substrate for eNOS
and functions as an endogenous eNOS inhibitor. In-
creased plasma levels of ADMA have been observed in
Table 2 Hydrodynamic particle size of E171 and E153 in suspension
vehicle for the ex vivo and in vivo studies
NTA
Mean (nm) Mode (nm) D10 (nm) D50 (nm) D90 (nm)
Ex vivo Study
E171 203 ± 75 264 ± 135 77 ± 69 179 ± 84 363 ± 126
Aeroxide
P25
101 ± 58 128 ± 120 27 ± 17 79 ± 56 204 ± 121
E153 204 ± 58 291 ± 130 79 ± 45 192 ± 70 340 ± 112
Printex 90 166 ± 27 224 ± 119 35 ± 20 13 ± 20 339 ± 72
In vivo Study
E171 270 ± 25 298 ± 58 163 ± 19 266 ± 28 374 ± 26
E153 230 ± 24 227 ± 61 137 ± 17 211 ± 24 347 ± 33
Hydrodynamic size distribution of particles used in the ex vivo and the in vivo
study was measured by the Nanoparticle Tracking Analysis (NTA). The data are
expressed as the mean, mode, distribution fractions D10, D50 and D90, ± SD.
Each experiment was repeated three times on different days
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Fig. 2 Hydrodynamic particle size distribution. The hydrodynamic size of the particles was determined with NanoSight LM20 and the Nanoparticle
Tracking Analysis software 3.0. Particles used in the ex vivo study was dispersed in DMEM (a). Particles used in the in vivo study was dispersed in
0.45 μm filtered sterile water added 2% FBS (b). The data are presented as the mean particle size (nm) from three independent experiments. On each
experimental day the mean of five following measurements were used
Fig. 3 Acetylcholine (ACh)-induced endothelium-dependent vasorelaxation of rat aorta segments exposed ex vivo to particles. The measurements
were performed with and without the addition of the NOS inhibitor, L-NAME. The acetylcholine response is expressed as the % relaxation of the
pre-contraction tension produced by PGF2a. Each point on the curves represents the cumulative response at each concentration of acetylcholine.
The data are presented as the mean ± SEM, n indicates the number of animals. An asterisk (*) denote a statistically significant effect on
Emax compared to the control group (P < 0.05)
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rats after exposure to concentrated fine ambient air
particles [14]. Malondialdehyde (MDA) is a lipid peroxi-
dation product and was measured as a marker of oxida-
tive stress.
In general, the plasma biomarkers were unaltered in
particle-exposed rats as compared to controls (Table 5).
Collectively, the results on plasma antioxidants (ascor-
bate and BH4) and oxidants (i.e., MDA, and BH2) dem-
onstrated no change in systemic oxidative stress in
response to the particle exposure in rats.
Discussion
The results of this study show that in vivo exposure to
food-grade TiO2 (E171) and vegetable carbon (E153)
was associated with a slightly altered endothelium-
dependent vasorelaxation and vasocontraction response
in coronary arteries. The same effects were observed in
aorta rings from naïve rats after direct exposure to E171
and E153. This consistency in ex vivo and in vivo re-
sponses should be noted, although it is equally import-
ant to note that the effects on vasomotor function did
not occur in a dose-dependent manner. The study repre-
sents an exposure to “real-life” particles in the relevant
route of exposure in humans after ingestion of either
food or pharmaceuticals. In general, the exposure to
E153 and E171 is higher in children than adults and
elderly [9, 10]. Nevertheless, the elderly, patients with
pre-existing diseases and adults with cardiometabolic
risk factors may be more suspectible to particle-induced
cardiovascular disease than children and adolescents.
A systematic review has demonstrated that the major-
ity of studies on particle exposure in animals and
humans show reduced endothelium-dependent vasore-
laxation and increased vasocontraction response in ar-
teries [15]. The immediate consequence of this effect is
an increased tone of the artery, which might be associ-
ated with elevated blood pressure. Thus, the increase in
both the vasorelaxation and vasocontraction response, as
found in the present study, is somewhat surprising,
although other studies have demonstrated similar re-
sponses. It has been observed that amorphous nano
silica particles induced vasorelaxation in thoracic aorta
rings of rats ex vivo, which was mediated through NO
by activation of PI3K/Akt/eNOS signaling [16]. Earlier
studies on high-dose pulmonary exposure to ambient
particulate matter also showed increased ACh-
dependent vasorelaxation in aorta rings from spontan-
eously hypertensive rats [17]. The same type of exposure
to ambient particulate matter provoked vasorelaxation
in aorta rings after ex vivo exposure [18, 19]. In our
Fig. 4 Nitroglycerine (NTG)-induced endothelium-independent vasorelaxation of rat aorta segments exposed ex vivo to particles. The nitroglycerine re-
sponse is expressed as the % relaxation of the pre-contraction tension produced by PGF2a. Each point on the curves represents the cumulative re-
sponse at each concentration of nitroglycerine. The data are presented as the mean ± SEM, n indicates the number of animals
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study, the increased vasorelaxation after ACh exposure
to vessels may originate from an eNOS-dependent path-
way since L-NAME abolished the effect in the ex vivo
study and the NTG-mediated vasorelaxation was un-
altered. It is possible that the concurrent increase in
both vasorelaxation and vasocontraction occur by differ-
ent mechanisms, although they may also be the product
of compensation in the vessel. The effect on vasomotor
function was seen in resistance arteries, whereas the
aorta (i.e., a conductance artery) was not affected. The
endothelium-dependent vasorelaxation in conductance
arteries is mainly driven by NO, whereas resistance ar-
teries also use endothelium-derived hyperpolarization
factor [20].
The effects on vasomotor function responses in the
in vivo study were in the range of 20–40% difference in
the distal LAD. To the best of our knowledge, there are
no observations on vasomotor function in humans after
oral exposure to particles. It has been shown that gastric
exposure to nanosized CeO2 produced a smaller impair-
ment of microvascular function in Sprague-Dawley rats
compared to the same dose administered by intratra-
cheal instillation [21]. However, a larger induction of ox-
idatively damaged DNA has been observed in the liver
after oral exposure to Printex 90 compared to the same
dose administered by intratracheal instillation to Fisher
F344 rats [22]. Previously, we have obtained less than
10% difference in microvascular function in humans
after controlled inhalation exposure to particulate matter
and the effect has been strongest in risk groups of car-
diovascular disease and elderly [23–29]. The magnitude
of the effects on vasomotor function in the present study
is modest, but they are also realistic, considering the
magnitude of exposure.
The toxicity of nanosized particles is typically consid-
ered to be related to inflammation and oxidative stress.
We chased this mechanism by analysis of plasma levels
of the lipid peroxidation products (MDA) and antioxi-
dants (ascorbate and BH4). However, these results did
not indicate a systemic oxidative stress reaction. It is im-
portant to emphasize that MDA was measured with a
validated HPLC assay. Likewise, care was taken to secure
plasma from spurious oxidation during sampling and
processing for the ascorbate and BH4 assays. It should
be noted that some studies have shown associations be-
tween exposure to particles and altered vasomotor func-
tion without systemic inflammation and oxidative stress
[3]. Still, oxidative stress and inflammation may occur in
the vascular wall as shown in a study where inhalation
of TiO2 generated microvascular dysfunction, concur-
rently with increased production of reactive oxygen spe-
cies and nitrosative stress [30]. Unfortunately, the lack of
Fig. 5 5-hydroxytryptamine(5-HT)-induced receptor-dependent vasocontraction of rat aorta segments exposed ex vivo to particles. The 5-HT re-
sponse is expressed as the % maximal contraction induced by stimulation with K+ before the dose-response measurements. Each point on the
curve represents the cumulative response at each concentration of 5-HT. The data are presented as the mean ± SEM, n indicates the number of
animals. An asterisk (*) denote a statistically significant effect on Emax compared to the control group (P < 0.05)
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oxidative stress indicators in plasma leaves the study
without a link in the causal pathway from external ex-
posure to the observed vasomotor function response in
the in vivo study. Nevertheless, we speculate that the
altered vasomotor response may be due to bioactive
components in plasma that interact with the cellular sig-
naling (e.g., NO production or delivery from endothelial
cells to smooth muscle cells) or increases the response
to vasoactive drugs. Previously, we have shown that
plasma from Printex 90 exposed mice caused vasocon-
traction in aorta rings from naïve mice [31]. This type of
bioactivity has been described in various studies on
pulmonary exposure to particulate matter [32].
Unfortunately, we did not have sufficient plasma to
measure plasma bioactivity.
The ex vivo experiments indicated that E171 and E153
could generate the same effects as observed in vivo after
oral exposure. In a previous study, we observed that fine,
nanosized and photocatalytic TiO2 increased the surface
expression of cell adhesion molecules in human umbil-
ical vein endothelial cells without concurrent generation
of reactive oxygen species [33]. We used Printex 90 as a
Fig. 6 Acetylcholine (ACh)-induced endothelium-dependent vasorelaxation of artery segments from rats exposed intragastrically to particles. The acetyl-
choline response is expressed as the % relaxation of the pre-contraction tension produced by PGF2a. Each point on the curves represents the cumulative
response at each concentration of acetylcholine. The data are presented as the mean ± SEM, n indicates the number of animals. An asterisk (*) denote a
statistically significant effect on Emax compared to the control group (P< 0.05)
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benchmark particle, which previously demonstrated in-
creased phenylephrine-mediated vasocontraction in mice
aorta rings following exposure to 100 μg/ml [11]. The
ACh-vasorelaxation response was mixed in the sense
that it was associated with a decreased response at
10 μg/ml and increased response at 100 μg/ml [11].
However, it should be noted that the exposure condi-
tions were different as the aorta rings were exposed dir-
ectly in the organ bath in the mouse study while in the
present study, rat aorta rings were exposed to particles
before they were mounted in the organ bath. Also, there
is a clear difference in species. In our previous study, we
also exposed rat mesenteric arteries to Printex 90 in a
pressure myograph, which demonstrated a decrease in
the vessel diameter, indicating an overall vasocontraction
response to Printex 90.
We did not measure cytotoxicity in the ex vivo study
because the exposure only lasted 30 min, which is too
short to detect a reliable response by conventional tech-
niques such as the lactate dehydrogenase activity and
WST-1 assays. In a previous study we did not observe
statistically significant increases in cytotoxicity in human
Fig. 7 Nitroglycerine-induced endothelium-independent vasorelaxation of artery segments from rats exposed intragastrically to particles. The
nitroglycerine response is expressed as the % relaxation of the pre-contraction tension produced by PGF2a. Each point on the curves represents
the cumulative response at each concentration of nitroglycerine. The data are presented as the mean ± SEM, n indicates the number of animals.
# denotes a statistically significant effect on log EC50 compared to the control group (P < 0.05)
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Fig. 8 5-hydroxytryptamine (5-HT)-induced receptor-dependent vasocontraction of artery segments from rats exposed intragastrically to particles. The
5-HT response is expressed as the % maximal contraction induced by stimulation with K+ before the dose-response measurements. Each point on the
curve represents the cumulative response at each concentration of 5-HT. The data are presented as the mean ± SEM, n indicates the number of
animals. An asterisk (*) denote a statistically significant effect on Emax compared to the control group (P < 0.05)
Table 5 Biochemical parameters in lean Zucker rats after repeated exposure to E171 and E153 by oral gavage
In vivo Study Control (n = 9) E171 (n = 9) E171 (n = 10) E153 (n = 10) E153 (n = 8)
Dose (mg/kg bw/week) 0 50 500 0.64 6.4
Vitamin C (μM) (ascorbate + DHA) 19.6 ± 2.9 20.3 ± 2.6 21.0 ± 4.6 20.5 ± 3.9 18.9 ± 2.9
MDA (μM) 0.20 ± 0.05 0.19 ± 0.08 0.22 ± 0.07 0.20 ± 0.07 0.19 ± 0.05
BH4 (nM) 150.1 ± 20.4 149.2 ± 18.9 154.8 ± 43.7 151.5 ± 20.5 134.5 ± 27.4
BH4/BH2 ratio (nM) 0.20 ± 0.04 0.18 ± 0.04 0.19 ± 0.04 0.17 ± 0.05 0.21 ± 0.05
ADMA (μM) 178.1 ± 31.8 192.3 ± 41.0 179.1 ± 47.0 219.8 ± 118.1 215.1 ± 89.4
L-arginine (μM) 51.0 ± 8.8 61.8 ± 15.8 58.3 ± 16.9 75.5 ± 54.1 75.1 ± 35.5
All biochemical parameters were measured in plasma samples taken at the time of sacrifice. bw: body weight, DHA dehydroascorbic acid, MDA malondialdehyde,
BH4 tetrahydrobiopterin, BH2 dihydrobiopterin, ADMA asymmetric dimethylarginine. Data are represented as mean ± SD
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umbilical vein endothelial cells (HUVECs) after 3 or
24 h exposure to Printex 90 [34]. Equivocal results on
Printex 90 in HUVECs were observed after 24-h expos-
ure periods as there was 20% increase in lactate
dehydrogenase (LDH) activity assay, whereas the WST-1
assay was unaltered after exposure to 100 μg/ml) [11].
On the other hand, a fine size carbon black (Flammrus
101) did not generate cytotoxicity in the LDH assay [33].
TiO2 has low toxicity as compared to other nanomater-
ials [35]. We have obtained mixed results with TiO2 in
HUVECs; one study showed no effect of fine and photo-
catalytic TiO2 particles, whereas a nanosized sample
generated approximately 20% cytotoxicity (LDH assay)
[33]. Another study actually showed a rather large effect
in the WST-1 assay after exposure to 7 nm anatase TiO2
and some rutile forms [36]. It should be noted that
HUVECs are adherent cells and the exposure may in-
crease during the incubation period because of sedimen-
tation of particles, whereas the aorta rings were exposed
in suspension in the present study. In addition, there is
no consensus about the role of cytotoxicity in ex vivo
studies on vasomotor function. In genotoxicology, it is
recommended that the level of cytotoxicity should not
increase more than 30% in assays for DNA damage such
as the comet assay [37].
There is no consistency in the available literature
concerning the uptake of TiO2 to the circulation [38].
Earlier studies on micro size (500 nm) TiO2 in rats
demonstrated a relatively high fraction of absorption
(approximately 6.5% of the administered dose) after
exposure by oral gavage to 12.5 mg/kg per day for
10 days [39]. However, a recent study demonstrated
only 0.6% absorption after a single small dose of radio-
actively labeled 70 nm TiO2 nanoparticles in rats [40].
E171 mainly consists of micro-sized TiO2 particles,
with less than 3.2% of the mass in the nanoscale range
[10]. Taking the dose level and particle size into consid-
eration, the exposure in our study may be more similar
to the observations of translocation of micro-sized
particles in rats.
Nevertheless, it appears safe to assume that the trans-
location is low. Uptake of TiO2 to the systemic circula-
tion has been described in humans [41]. It is even more
unclear whether carbon-based particles translocate to
the systemic circulation because it is more difficult to
measure carbon material than metals in tissues.
Conclusion
This study shows that 10 weeks of intragastric exposure
to vegetable carbon (E151) or food-grade TiO2 (E171)
was associated with modest albeit statistically significant
alterations in the vasomotor response in coronary arter-
ies, without evidence of systemic oxidative stress.
Methods
Particles
E153 (Norit N.V., Amersfoort, The Netherlands, distrib-
uted by Medic Team A/S, Allerød, Denmark) was
purchased as an over-the-counter drug in a local phar-
macy. Each package contained 30 gelatine capsules with
200 mg vegetable carbon powder. Norit is marketed as a
drug for treatment of acute poisoning and diarrhea; it is
commonly described as “activated charcoal” or “activated
carbon”. The gelatine capsule was discharged, and the
internal powder content was stored in a sterile container.
Food-grade TiO2 was bought as a white coloring agent
(E171) at a Danish webshop (www.bolsjehuset.dk).
Aeroxide P25 was obtained from Sigma-Aldrich (prod-
uct number 718467, declared primary particle size of
21 nm). Printex 90 was kindly supplied from Degussa-
Hüls, Frankfurt, Germany (declared primary particle
size of 14 nm).
We characterized E171 and E153 with both
transmission electron microscopy and specific surface
areas. The latter used nitrogen adsorption according to
the Brunauer, Emmet and Teller method [42]. The ana-
lysis was performed at Quantachrome Instruments
(LabQMC, Boynton Beach, FL, USA). Particles were sus-
pended in water with 2% FBS in a concentration of
100 μg/ml for the visualization in TEM. A few drops of
the suspension were applied on TEM grids and dried
[43]. Afterwards the TEM grids were inspected in a
Phillips CM20 transmission microscope at 5800 and
44,000 magnification. We measured the size of individ-
ual particles using ImageJ software (https://imagej.nih.-
gov) on digital images from two different grids, which
were prepared on the same day of analysis.
Zeta potential was measured on a Brookhaven
ZetaPALS (Brookhaven Instruments, Holtsville NY, USA)
and a Zetasizer Nano ZS (Malvern Instruments, Malvern,
UK). E171 and E153 were sonicated for 30 min at 60 Hz
using a VWR UltraSonic Cleaner (VWR, Radnor PA,
USA) and diluted to 0.2 mg/mL in PBS (P4417, Sigma).
Measurements were on both instruments performed using
a dip cell. On the ZetaPALS instrument, ten runs on three
different particle suspensions were done, on the Zetasizer,
three runs were done on the same samples. Reported
values in Table 1 are from the Zetasizer, the encountered
fluctuations in signal were observed on the ZetaPALS.
The hydrodynamic particle size in suspension was de-
termined by the Nanoparticle Tracking Analysis (NTA).
The particles were sonicated as described below and di-
luted to a final concentration of approximately 10 μg/ml.
The samples were analyzed on a NanoSight LM20
(Nanosight Ltd., Malvern Instruments, Malvern, UK)
with a blue (450 nm) laser. All measurements were re-
peated on three different days. On each experimental
day, five consecutive measurements on the same particle
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suspension were assessed, and the mean was used for
data analysis.
For the ex vivo and in vivo study particle stock sus-
pensions were prepared by dispersing particles in either
0.45 μm filtered sterile water added 2% FBS (ref.
10,500–064, Gibco®) (in vivo study) or DMEM cell cul-
ture medium (Dulbecco’s modified eagle medium,
D5796, Sigma) (ex vivo study), using a Branson Sonifier
mounted with a disruptor horn (Model S-450D,
Branson Ultrasonics Corp., Danbury, CT, USA) in the
in vivo study or using a Vibra Cell Vc50t, Ultrasonic
Processor 20 kHz (R125136, Sonics & Materials,
Newtown, Connecticut, USA) in the ex vivo study. Stock
suspensions were sonicated for 16 min without pause and
continuously cooled on ice, according to the recommen-
dations in the protocol that was developed for the EU
Framework 7 project “Risk assessment of engineered
nanoparticles” (ENPRA; http://www.enpra.eu). Stock
suspension concentrations were in the ex vivo study
1.4 mg/ml for E171 and Aeroxide P25 and 1.0 mg/ml for
E153 and Printex 90. Stock suspensions for the in vivo
study were 120 mg/ml for E171 and 1.6 mg/ml for
E153. The stock solutions were prepared the same day
of use and used immediately after sonication (vortexed
before use) after dilution with dispersion media to final
concentrations.
Animal model and study design
Ex vivo study
Eleven female Sprague-Dawley rats were purchased from
Taconic (Ejby, Denmark). The rats were aged between
14 and 17 weeks when sacrificed and weighed 297 ±
21 g. The rats were acclimatized for minimum 1 week
before entering the study. The rats were housed in pairs,
in an enriched environment, with free access to tap
water and standard chow. The cages were housed in an
animal facility with a 12 h day-night cycle in a
temperature (20–24 °C) and moisture (55%) controlled
room. At the day of the experiment, one rat was sacri-
ficed. The rat was anesthetized with a subcutaneous in-
jection (in the lower back) of a combination of hypnorm
(fentanyl 0.315 mg/ml and fluanisone 10 mg/ml) and
dormicum (midazolam, 5 mg/ml) (0.3 ml/100 g bw), and
decapitated following deep anesthesia and concomitant
disappearance of voluntary reflexes. The heart with the
aorta was isolated and put in a glass vial containing
ice-cold PSS buffer, until dissection in the laboratory fa-
cilities immediately thereafter. PSS had the following
composition: 119.0 mM NaCl, 4.7 mM KCl, 1.5 mM
CaCl2, 1.2 mM MgSO4, 1.2 KH2PO4 mM, 0.027 EDTA
mM, 6.05 mM glucose, 25.0 mM NaHCO3. pH was 7.4
when the solution was gassed with 95% O2 and 5% CO2
mixture. The aorta was dissected free of fat- and con-
nective tissue in a petri dish containing ice cold PSS and
cut into segments of approximately 2 mm in length and
incubated for 30 min in particle suspension (DMEM) (in
a 12-well plate/2 ml per well) at 37 °C with 5% CO2.
Particles and concentrations were either E171 (14 or
140 μg/ml), Aeroxide P25 (14 or 140 μg/ml), E153 (10
or 100 μg/ml) or Printex 90 (10 or 100 μg/ml). After the
exposure to particles, the aorta rings were carefully
washed in a physiological saline solution (PSS) and
mounted in a wire myograph. Each segment was nor-
malized to a standard pressure of 13.3 kPa, and an
internal circumference (IC) set to 90% (IC90) of the
IC100 (pressure at 100 mmHg). After a 30 min equilibra-
tion period, the rings were stimulated with a high potas-
sium concentration to test their viability and then
preconstricted with prostaglandin F2α (PGF2α) before va-
sorelaxation studies. There was no difference between
the precontraction ability of aorta rings that had been
exposed to particles or vehicle (results not shown). The
rings were challenged with vasoactive compounds as
described below.
In vivo study
Lean Zucker rats were used because of previous findings
of endothelial dysfunction in aorta rings in this strain after
exposure to Printex 90 [6]. The study showed similar
vasomotor dysfunction response in both lean and obese
Zucker rats, and therefore the less expensive lean Zucker
rat was chosen as a model animal in this study. The obese
Zucker rat is an animal model for metabolic syndrome,
and it develops vasomotor dysfunction [6, 44].
Fifty, female lean Zucker rats (Crl:ZUC-Leprfa, strain
code 138), were purchased from Charles River (distrib-
uted in Denmark by Scanbur, Karlslunde, Denmark).
The rats were between 8 and 13 weeks of age and accli-
matized for at least 1 week before entering the study. All
rats were randomly assigned to one of five exposure
groups; vehicle, low-dose E153 (0.64 mg/kg bw/week),
high-dose E153 (6.4 mg/kg bw/week), low-dose E171
(50 mg/kg bw/week) or high-dose E171 (500 mg/kg bw/
week). Each exposure group included ten rats. The
group size was based on a power calculation of previous
results on vasomotor function in the aorta of Printex 90
exposed lean Zucker rats [6] (calculations not shown).
The rats were housed in pairs in cages with standard
bedding and nesting materials. Rats, living in the same
cage, were assigned to the same exposure, to avoid the
possibility of cross-contamination of particles via, e.g.,
ingestion of stool pellets. The rats had unlimited access
to standard rodent chow (Altromin no. 1319) and tap
water. None of the rats were euthanized before the end
of the exposure period due to discomfort, assessed as
excessive loss of body weight (exceeding 20% over a
week). The bodyweights before (188 ± 20 g) and after
(239 g ± 15 g) the exposure period were not different
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between groups (mean and standard deviation). Particles
were administered to the rat by oral gavage of 1 ml
particle suspension or vehicle, with the use of a plastic
feeding tube (15ga × 100 mm, Instech Laboratories,
Winsum, the Netherlands). The rats were weighed the
day before exposure, and the particle stock suspension
was adjusted to individual weight. Control rats received
a bolus of 1 ml dispersion media, sonicated as described
above, but without particles. Animals were exposed once
a week, for 10 weeks. Oral gavage was executed on the
same weekday and time a day for each animal. The
procedure was performed by an experienced animal tech-
nician to minimize stress and discomfort in the rats. At
the day of the experiment, two rats, from different expos-
ure groups, was sacrificed. The rat was anesthetized 24 h
after the last exposure, with a subcutaneous injection (in
the lower back) of a combination of hypnorm (fentanyl
0.315 mg/ml and fluanisone 10 mg/ml) and dormicum
(midazolam, 5 mg/ml) (0.3 ml/100 g bw), following death
by exsanguination due to blood collection.
Biochemical parameters in plasma
Blood was collected by abdominal aortic puncture using
a 21 gauge needle equipped with a syringe (without anti-
coagulant). Approximately 4 ml blood was immediately
transferred to an ethylenediamine-tetraacetic acid
(EDTA) K3 tube (2.1 mg/ml EDTA K3, Venosafe®) and
plasma was collected after centrifugation (2000 g, 4 °C
for 5 min). The remaining blood was set to coagulate in
an Eppendorf tube, and serum was collected by centrifu-
gation (2000 g, 4° for 5 min). Plasma from EDTA treated
blood was used to measure concentrations of MDA and
ADMA. For measurement of BH4, EDTA treated blood
was added 4% dithioerythritol and plasma were collected
by centrifugation (1500 g, 4 °C for 1 min). For measure-
ment of vitamin C, 10% metaphosphoric acid was added
to plasma from EDTA tubes and stored at − 80 °C until
analyzed. Plasma concentrations of BH4, vitamin C,
MDA, and AMDA were measured by HPLC with fluor-
escent detection [45–48].
Vasomotor function assessed by the wire myograph method
The procedure for assessing vasomotor function was
similar in the ex vivo- and the in vivo study. In the
ex vivo study, segments of the aorta was incubated with
particles for 30 min and then assessed for vasomotor
responses. In both the ex vivo- and in vivo study seg-
ments of the aorta was used. In the in vivo study, we
also chose to include segments of both the proximal and
distal segments of the LAD. This was due to possible
differences in vasomotor responses in LAD segments
compared to the aorta. LAD mainly resembles resistance
arteries whereas the aorta is a conductance artery, in
addition, coronary arteries are a common site for
atheroma formation. The vasomotor function was ana-
lyzed immediately after the rats were sacrificed and
blood was collected. The heart with aorta was excised
from the rats and kept in ice-cold PSS before dissection.
Before dissection, the heart and aorta were secured gen-
tly with entomology pins in a petri dish with a thick
layer of clear silicone gel in the base. The tissue was cov-
ered with Ca2+free PSS buffer. This buffer had the same
composition as PSS, only CaCl2 was omitted, and 1 μM
ethylene glycol tetraacetic acid was added. The dissec-
tion was done in Ca2+free PSS buffer to avoid unneces-
sary vessel contraction. The aortic root and arch were
gently trimmed free of connective- and fat tissue under
a dissecting microscope. One segment of the ascending
aorta cut immediately before the three large side
branches of the aortic arch, was cut into a ring-shaped
segment of approximately 2 mm in length. The vessel
was carefully cannulated with two stainless steel wires
(40 μm in diameter) and mounted in the organ bath of a
Multi-Wire Myograph 620 M (Danish Myo Technology,
Aarhus, Denmark) interfaced to a PowerLab4/35 re-
corder (ADInstruments). The organ bath was filled with
cold, oxygenated Ca2+free PSS buffer (5 ml) and con-
tinuously perfused with a 95% O2 and 5% CO2 gas mix-
ture. Perfusion with the gas mixture was continuously
done throughout the entire experimental procedure. In
the in vivo study, we also included two segments of the
LAD artery. The LAD artery was dissected free from the
heart by carefully removing a part of the myocardial
tissue. One segment of the LAD proximal to the aortic
root, and one segment distal to the aortic root (nearer
the apex) were cut into ring-shaped segments of ap-
proximately 2 mm in length. The LAD segments were
mounted in organ baths as described for the aorta but
cannulated with a stainless steel wire of 25 μm in diam-
eter. When finished mounting, Ca2+free PSS buffer was
removed from the organ bath, and replaced by cold PSS.
The heat was turned on to 37 °C, and the segments were
allowed to equilibrate for 30 min. All baths were main-
tained at 37 °C throughout the experiment. The DMT
LabChart normalization procedure was used, to set
vessels to standard initial conditions. Normalization was
done to ensure that the physiological responses of the
vessels were assessed reliably. With normalization, the
internal circumference a vessel would have if relaxed
and under a transmural pressure of 100 mmHg (IC100),
is determined. The maximal active tension was set to
90% (IC1) of IC100, which is optimal at this point. After
normalization, the vessel viability was confirmed by the
use of a “wake-up” protocol. The protocol consisted of
stimulation with 37 °C potassium physiological salt
solution (KPSS). KPSS had the same constituents as PSS
but without NaCl and the concentration of KCl was
125 mM. KPSS induces non-receptor mediated
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vasocontraction, due to depolarization of the cell by en-
hancing extracellular influx of calcium. The contraction
was allowed to stabilize and reach a plateau before adding
PSS. The stimulation was repeated three times, and only
responsive vessels were used in the further experiments.
ACh (acetylcholine chloride, Sigma Aldrich) was used to
assess the endothelium-dependent vasorelaxation in
PGF2α (3–10 μM) (dinoprost trometamol 5 mg/mL,
Glostrup apotek, Denmark) precontracted vessels. The
particle exposure did not alter the precontraction ability
with PGF2α (results not shown). ACh was cumulatively
added to the organ bath (0.1 nM - 0.3 mM in aorta,
0.1 nm - 0.03 mM in LAD), each concentration was
allowed to reach a plateau before adding the next
concentration. To assess if the ACh-induced relaxation
were dependent on eNOS, some of the arteries in the
ex vivo study (n = 3–5) were incubated with the NOS in-
hibitor L-NAME (N5751, Sigma-Aldrich) for 15 min (10−
5 M), before an additional concentration-response curve
with acetylcholine were assessed.
To assess the endothelium-independent vasorelax-
ation, the NO donor nitroglycerin (NTG) (glyceryl ni-
trate 5 mg/mL, Region H’s Apotek, Herlev, Denmark)
was added to the organ bath in a cumulative manner
(ex vivo: 0.01 nm - 0.03 mM; in vivo: 0.1 nm 0.03 mM)
after inducing a stable contraction in the vessels with
PGF2α. The arteries responses to receptor-dependent
vasocontraction were assessed with 5-hydroxytryptamine
(5-HT, serotonin hydrochloride, H9523, Sigma Aldrich)
(ex vivo: 10 nm - 0.3 mM; in vivo: 3.0 nm 0.3 mM).
Between the cumulative concentration-response
curves with ACh, NTG, and 5-HT, the vessels were
washed with PSS and contracted once with KPSS. The
precontraction response with PGF2α was expressed as
the percentage of the maximal contraction when stimu-
lating the vessels with K+ (125 mM). Vessels precon-
tracted to 10–150% of the maximal K+ induced
contraction was included in the study. There was no dif-
ference between groups in the precontraction response.
The vasorelaxation caused by ACh and NTG were
expressed as the percentage relaxation of the precontrac-
tion tension produced by PGF2α. The contraction caused
by 5-HT were expressed as the percentage of the
maximal contraction obtained when stimulating the ves-
sel segments with K+ (125 mM) before the 5-HT
concentration-response curve. Data on vasomotor re-
sponse were excluded from the study if segments did
not respond to K+ stimulation, there were missing values
in the cumulative concentration-response curves, data
could not be fitted to a sigmoid curve with nonlinear re-
gression analysis or if the segment could not be
mounted in the organ bath due to technical difficulties.
Animals from different exposure groups were analyzed
on the same experimental day.
Statistical analysis
All concentration-response curves were analyzed by non-
linear regression analysis using GraphPad Prism version 7
(San Diego, CA, USA). The data were fitted to sigmoid
curves with varying slopes according to the following
equation: Y = Bottom + (Top – Bottom)/ (1 + 10^((Log
EC50 – X) * Hill Slope)), where X is the logarithm of con-
centration and Y is the response. Y starts at Bottom and
goes to Top with a sigmoid shape. The data points on
each curve are expressed as mean ± SEM and n denotes
the number of rats. Non-overlapping confidence intervals
were considered to be statistically different. Values of Emax
(top value) and Log EC50 values were compared.
Data on biomarkers measured in plasma was analyzed
by one-way ANOVA with Dunnett’s post-tests. All statis-
tical analyses were considered significant when P < 0.05.
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